patient safety

patient safety

featured image of Revolutionizing ADC Manufacturing for Safer Cancer Treatments!

Revolutionizing ADC Manufacturing for Safer Cancer Treatments!

BIOT

Discover how Repligen's integrated solutions are revolutionizing ADC manufacturing, enhancing safety, efficiency, and real-time analytics for better cancer treatments! 🧪📊✨

featured image of Hidden Germs in Cleanrooms: What You're Missing!

Hidden Germs in Cleanrooms: What You’re Missing!

BIOT

🦠 New research uncovers hidden cleanroom contaminants missed by traditional methods, emphasizing improved monitoring and advanced detection for safety! 🔍💡⚠️

featured image of Unlocking Biopharma: WuXi's PAT Revolution!

Unlocking Biopharma: WuXi’s PAT Revolution!

BIOT

🌟 WuXi Biologics champions PAT in BioPharma, enhancing control and quality assurance for rapid therapy development! 📊🔬💡 BiotechInnovation

featured image of Revolutionizing CGT Supply Chains for Patient Safety!

Revolutionizing CGT Supply Chains for Patient Safety!

BIOT

Unlock the future of CGT! 🚀 Discover how TrakCel's Ocellos system standardizes supply chains, enhancing visibility, compliance, and patient safety. 📈🔄

featured image of Revolutionary Monoclonal Antibodies: Unleashing Advanced Therapies

Revolutionary Monoclonal Antibodies: Unleashing Advanced Therapies

BIOT

🔍 Monoclonal antibodies (mAbs) have paved the way for advanced therapies, thanks to decades of development and manufacturing improvements. 💪

featured image of Patient Advocate Slams FDA's CAR-T Warning Labels: Is Patient Safety at Risk?

Patient Advocate Slams FDA’s CAR-T Warning Labels: Is Patient Safety at Risk?

BIOT

🔺 Patient advocate slams FDA decision on CAR-T warning labels, arguing it undermines patient knowledge and autonomy. 🔺 Warning labels may deter patients from seeking life-saving CAR-T therapies. 🔺 Advocates prioritize informed consent and patient education over warnings. 🔺 Critics fear labels could cause unnecessary fear and anxiety. 🔺 FDA decision raises concerns on patient safety vs. access to innovative therapies.